MISC

1992年11月

PROTECTIVE EFFECT OF DILTIAZEM HYDROCHLORIDE ON THE OCCURRENCE OF ALLOXAN-INDUCED OR STREPTOZOTOCIN-INDUCED DIABETES IN RATS

HORMONE AND METABOLIC RESEARCH
  • K KATSUMATA
  • ,
  • K KATSUMATA
  • ,
  • Y KATSUMATA

24
11
開始ページ
508
終了ページ
510
記述言語
英語
掲載種別
出版者・発行元
GEORG THIEME VERLAG

This study demonstrated that 20 mg/kg of the Ca2+ channel blocker, diltiazem hydrochloride, administered by intraperitoneal injection 15 min before 200 mg/kg of alloxan given by the same route to induce diabetes, served to suppress disease onset completely in rats. Even though 48-h fasting promoted the onset of alloxan diabetes, 40 mg/kg of diltiazem hydrochloride completely prevented the occurrence of diabetes induced by intraperitoneal injection of 200 mg/kg of alloxan. Forty mg/kg of the same agent, however, failed to prevent the onset of diabetes induced by the intravenous injection of streptozotocin (50 mg/kg). From the fact that Ca2+ channel blockers such as nicardipine, verapamil and bepridil have a similar suppressive effect on the occurrence of alloxan diabetes, one may readily infer that this action is characteristic of Ca2+ channel blockers. Moreover, the results suggest the close connection of Ca2+ in the occurrence of alloxan diabetes in rats.

リンク情報
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:A1992JX93400003&DestApp=WOS_CPL
ID情報
  • ISSN : 0018-5043
  • Web of Science ID : WOS:A1992JX93400003

エクスポート
BibTeX RIS